Here are relevant reports on : pulmonary-arterial-hypertension-market
-
Pulmonary Arterial Hypertension Market by Drug Class (SGC Stimulators, Endothelin Receptor Antagonists, Type (Innovative, Generics) – Global Forecast to 2027
The global pulmonary arterial hypertension market is projected to reach USD 9 billion by 2027 from USD 7 billion in 2022, at a CAGR of 5% during the forecast period
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Hypertension Management Devices Market - Global Trends, Opportunities and Forecasts to 2017 - [Renal Denervation, Carotid Artery Stimulation, Respiratory Modulation]
Treatment of hypertension is experiencing change as traditional drug based approach is giving way to treatment with devices which acts on Renal Sympathetic denervation as well as Carotid Sinus Stimulation and novel devices such as respiratory modulation devices.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030
The global blood gas analyzer market, valued at US$2.61 billion in 2024, stood at US$2.70 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2024 to 2030, culminating in a forecasted valuation of US$3.38 billion by the end of the period. Growth is being driven by the rising prevalence of chronic and acute diseases, increasing demand for rapid and accurate diagnostics, and continuous advancements in blood gas analyzer technology.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Catheter Stabilization Devices Market by Product ((Arterial, CVS (Portal, Femoral), Chest, Epidural, Peripheral (Nasogastric, Endotracheal, Foley)), Application (Cardiovascular, Respiratory), End User - Global Forecasts to 2025
The global catheter stabilization devices market growth is primed to transition from $1.18 billion in 2020 to $1.90 billion by 2025, showcasing a strong CAGR of 10.0%. The emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of heart and other life style diseases.
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Cannula Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020
The cannula market is estimated to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020.The report segments the global cannula market by product, by material, by application, by end-users and region. On the basis of material, the market is divided into plastic, metal and silicone. The silicone material is estimated to be the fastest growing segment during the forecast period. On the basis of end users, the cannulas market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities).
- Published: April 2015
- Price: $ 4950
- TOC Available:
-
Cardiac Perfusion Market by Product (Oxygenation Systems, Reservoirs, Heart-Lung Machines, Arterial Filters, Heat Transfer Systems, Blood Monitoring Systems, Auto transfusion Systems) - Forecast to 2020
Cardiac perfusion systems are used to temporarily replace the functions of the heart during cardiac surgeries. The cardiac perfusion system market is broadly segmented into oxygenation systems, reservoirs, heart-lung machines, myocardial protection systems, arterial filters, blood monitoring systems, autotransfusion systems, hemoconcentrators, heat transfer systems, tubings and cannulae, and others. The pivotal factor driving the growth of this market is increasing number of cardiac surgeries. Increasing prevalence of cardiac and lung diseases in developed as well as developing further propels the growth of this market. However, insufficient number of well-trained surgeons in developing nations, unstable reimbursement policies, and competition from local players with low cost products are inhibits the growth of this market. North America is the largest market for cardiac perfusion system market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of cardiac and lung surgeries and technological advancement in cardiac perfusion system. However, a majority of the growth in the cardiac perfusion system market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of cardiovascular patients, increasing awareness towards healthcare, and technological advancement in cardiovascular surgery in these regions.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Forecast to 2031
The vascular access device market, valued at USD 5.92 billion in 2025, stood at USD 6.27 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.68 billion by the end of the period. The market's expansion is attributed to the increasing prevalence of chronic diseases requiring frequent or long-term treatment through IV, such as cancer, heart disease, and kidney failure.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End User, Region - Global Forecast to 2028
The global carrier screening market, valued at US$1.8 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 19.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.4 billion by the end of the period. The expansion of this market is majorly due to the development and availability of expanded carrier screening panels that cover a wide range of genetic conditions contribute to the market's growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market is projected to reach USD 2,922.82 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
- Published: March 2014
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
